The estimated Net Worth of Douglas Kerr is at least $945 millier dollars as of 29 January 2024. Dr Kerr owns over 5,021 units of Generation Bio Co stock worth over $944,534 and over the last 4 years he sold GBIO stock worth over $0.
Dr has made over 13 trades of the Generation Bio Co stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 5,021 units of GBIO stock worth $12,251 on 29 January 2024.
The largest trade he's ever made was exercising 14,876 units of Generation Bio Co stock on 15 July 2022 worth over $36,297. On average, Dr trades about 7,212 units every 65 days since 2021. As of 29 January 2024 he still owns at least 387,104 units of Generation Bio Co stock.
You can see the complete history of Dr Kerr stock trades at the bottom of the page.
Dr. Douglas Kerr M.B.A., M.D., Ph.D. is the Chief Medical Officer at Generation Bio Co.
Dr D is 54, he's been the Chief Medical Officer of Generation Bio Co since . There are 1 older and 4 younger executives at Generation Bio Co. The oldest executive at Generation Bio Co. is Dr. Robert Kotin Ph.D., 65, who is the Co-Founder & Advisor.
Douglas's mailing address filed with the SEC is 1560 TRAPELO ROAD, , WALTHAM, MA, 02451.
Over the last 4 years, insiders at Generation Bio Co have traded over $37,722,950 worth of Generation Bio Co stock and bought 4,282,125 units worth $70,408,633 . The most active insiders traders include Jason P Rhodes, Biomedical Innovation Maste... et Public Equities, L.P.Minne .... On average, Generation Bio Co executives and independent directors trade stock every 11 days with the average trade being worth of $116,471. The most recent stock trade was executed by Yalonda Howze on 15 July 2024, trading 3,347 units of GBIO stock currently worth $8,167.
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co executives and other stock owners filed with the SEC include: